These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6676174)

  • 1. [Rubella immunization with HPV77DE5 and RA 27/3 vaccines of 11 to 16-year-old girls: studies of antibody formation and antibody resistance after 4 and 8 years].
    Gitmans U; Enders G; Glück H; Harm B; Lindemann L
    Immun Infekt; 1983 May; 11(3):79-90. PubMed ID: 6676174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of young women vaccinated against rubella virus for 10 years in Taiwan.
    Lin DB; Kao CL; Lee CY
    Southeast Asian J Trop Med Public Health; 1996 Dec; 27(4):707-14. PubMed ID: 9253871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improvement of rubella vaccination. Seroconversion after serial rubella vaccination with the jet injector].
    Weber HG; Willers H
    Fortschr Med; 1982 Jun; 100(24):1161-3. PubMed ID: 7106679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Investigations on the immune response against meningococcal polysaccharide in children (author's transl)].
    Ambrosch F; Stanek G; Jürgenssen O
    Immun Infekt; 1980; 8(1):11-8. PubMed ID: 6773879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
    Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
    Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rubella immunization--immunity after 4 years (author's transl)].
    Petersen EE; Neumann-Haefelin D; Kärnbach M; Haas R
    Dtsch Med Wochenschr; 1977 Jul; 102(26):954-8. PubMed ID: 885075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the effects of active rubella vaccination. Comparative studies of the evaluation of seroconversion using the ELISA technic and the hemagglutination inhibition test].
    Dennin RH; Husstedt W
    Fortschr Med; 1983 Mar; 101(11):482-5. PubMed ID: 6343205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of immunoglobulin M-antibodies after rubella immunization with RA27/3 attenuated live vaccine in teen-agers: remaining problems.
    Braito A; Fanti O; Rossolini GM; Cellesi C
    Boll Ist Sieroter Milan; 1991-1992; 70(1-2):443-8. PubMed ID: 1670047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rubella immunization of teenage girls in Iceland and follow-up after a severe rubella epidemic.
    Rafnar B
    Bull World Health Organ; 1982; 60(1):141-6. PubMed ID: 6979417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reasons for repeated serologically unsuccessful (HAI-HIG test) rubella vaccination (author's transl)].
    Ehrengut W; Florent G
    Dtsch Med Wochenschr; 1981 Jul; 106(31-32):987-9. PubMed ID: 7261921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of two lots of Wister RA 27/3 rubella virus vaccine in young children.
    Thind IS
    J Hyg Epidemiol Microbiol Immunol; 1980; 24(4):439-47. PubMed ID: 7462613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to rubella and borderline immunity.
    Fogel A; Barnea B; Gerichter CB
    Isr J Med Sci; 1983 Oct; 19(10):934-5. PubMed ID: 6363349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
    Schluederberg A; Horstmann DM; Andiman WA; Randolph MF
    J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunoglobulin response to reimmunization with rubella vaccine.
    Scott RM; Schydlower M; Lampe RM; Schwab JA; Muelenaer AA
    J Pediatr; 1981 Oct; 99(4):531-4. PubMed ID: 7277092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective and controlled mass rubella vaccination - experiences with an economical method (author's transl)].
    Zippel C; Federmann G; Leidel J; Eggers HJ
    Immun Infekt; 1982 Mar; 10(2):69-75. PubMed ID: 7040210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of rubella antibodies and the results of vaccination against rubella in young women].
    Kopeć J; Zgórniak-Nowosielska I
    Przegl Epidemiol; 1994; 48(4):475-9. PubMed ID: 7597186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phases 3 and 4 immunization immunogenicity with combined measles-rubella vaccine].
    Ozaki T; Nishimura N; Gotoh K; Ohe K; Funahashi K; Maeda K; Okuno Y
    Kansenshogaku Zasshi; 2011 May; 85(3):250-5. PubMed ID: 21706844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.